Carbon Dots-Cisplatin Nano Drug Delivery System Induces the Death of Oral Tongue Squamous Cell under Self-Targeting Chemical/photodynamic Combined Therapy

Yue Wang,Meijun Du,Jing Wang,Ziyang Bai,Chenying Cui,Jiahui Tong,Yingyu Liu,Susu Guo,Wenjun Zhang,Xiuping Wu,Bing Li
DOI: https://doi.org/10.1016/j.colsurfa.2024.135511
2025-01-01
Abstract:Hypothesis Chemotherapy is effective against oral squamous cell carcinoma (OSCC), but its utility is hindered by significant side effects and drug resistance. Photodynamic therapy (PDT) offers a less invasive alternative, but challenges remain due to the hydrophobic nature of most photosensitizers (PS), limiting their effectiveness. A novel nano-composite, combining hyaluronic acid-carbon dots (HA-CDs) with cisplatin (DDP), may overcome these limitations by improving drug hydrophobicity and enabling dual-function therapy. Experiments Hyaluronic acid-carbon dots (HA-CDs) were synthesized via a hydrothermal method using hyaluronic acid as the primary precursor. The resulting HA-CDs were then combined with cisplatin (DDP) to form the HA-CDs-DDP composite, designed to enhance DDP hydrophobicity and serve as both a chemotherapy agent and a PS. Findings The HA-CDs-DDP composite facilitates self-targeting chemotherapy while acting as an intrinsic photosensitizer, eliminating the need for additional PS. The composite generated reactive oxygen species (ROS), effectively inhibiting tumor growth in vivo. This study demonstrates the potential of HA-CDs-DDP to induce cell death in OSCC via a combined chemotherapy/photodynamic therapy pathway, providing a promising new approach for clinical OSCC treatment.
What problem does this paper attempt to address?